Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|September 19, 2022
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibodyCarina Lynn Gehlert, Pegah Rahmati, Ammelie Svea Boje, et al.
Journal of Immunological Methods|August 23, 2011
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCCRoland Repp, Christian Kellner, Anja Muskulus, et al.
Cancer Research|December 5, 2015
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In VivoStefan Lohse, Saskia Meyer, Laura A P M Meulenbroek, et al.
Neoplasia (New York, N.Y.)|April 13, 2012
Oncogenic KRAS impairs EGFR antibodies' efficiency by C/EBPβ-dependent suppression of EGFR expressionStefanie Derer, Sven Berger, Martin Schlaeth, et al.
Frontiers in Immunology|November 17, 2022
Dual checkpoint blockade of CD47 and LILRB1 enhances CD20 antibody-dependent phagocytosis of lymphoma cells by macrophagesTobias Zeller, Sebastian Lutz, Ira A Münnich, et al.
Blood|April 22, 2022
Combining daratumumab with CD47 blockade prolongs survival in preclinical models of pediatric T-ALLKristina Müller, Fotini Vogiatzi, Dorothee Winterberg, et al.
Blood|May 7, 2025
Augmented CD47 expression impairs alloreactive T-cell clearance after allo-HCTCindy Sheree Flamann, Haroon Shaikh, Carina Matos, et al.
Haematologica|June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamabAlexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
Blood Advances|July 12, 2022
Venetoclax enhances the efficacy of therapeutic antibodies in B-cell malignancies by augmenting tumor cell phagocytosisFotini Vogiatzi, Julia Heymann, Kristina Müller, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 10, 2024
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytesRoland Windisch, Sarah Soliman, Adrian Hoffmann, et al.
Pageof 8